Cited by 44Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsMesenchymal stem cell research

Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination

Open access
Rodriguez, Enrique Garea, Wegner, Christiane, Kreutzfeldt, Mario, Neid, Katharina, Thal, Dietmar R., Jürgens, Tanja, Brück, Wolfgang, Stadelmann, Christine +1 more·2014·Acta Neuropathologica

Abstract

Cerebral cortex shows a high endogenous propensity for remyelination. Yet, widespread subpial cortical demyelination (SCD) is a common feature in progressive multiple sclerosis (MS) and can already be found in early MS. In the present study, we compared oligodendroglial loss in SCD in early and chronic MS. Furthermore, we addressed in an experimental model whether repeated episodes of inflammatory SCD could alter oligodendroglial repopulation and subsequently lead to persistently demyelinated cortical lesions. NogoA(+) mature oligodendrocytes and Olig2(+) oligodendrocyte precursor cells were examined in SCD in patients with early and chronic MS, normal-appearing MS cortex, and control cortex as well as in the rat model of repeated targeted cortical experimental autoimmune encephalomyelitis (EAE). NogoA(+) and Olig2(+) cells were significantly reduced in SCD in patients with chronic, but not early MS. Repeated induction of SCD in rats resulted only in a transient loss of NogoA(+), but not Olig2(+) cells during the demyelination phase. This phase was followed by complete oligodendroglial repopulation and remyelination, even after four episodes of demyelination. Our data indicate efficient oligodendroglial repopulation in subpial cortical lesions in rats after repeated SCD that was similar to early, but not chronic MS cases. Accordingly, four cycles of experimental de- and remyelination were not sufficient to induce sustained remyelination failure as found in chronic cortical MS lesions. This suggests that alternative mechanisms contribute to oligodendrocyte depletion in chronic cortical demyelination in MS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1260-8

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. [1]Adelmann M Wood J Benzel I The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat J Neuroimmunol 1995 63 17 27 10.1016/0165-5728(95)00124-7 8557821 · DOI
  2. [2]Albert M Antel J Bruck W Stadelmann C Extensive cortical remyelination in patients with chronic multiple sclerosis Brain Pathol 2007 17 129 138 10.1111/j.1750-3639.2006.00043.x 17388943 PMC8095564 · DOI · Paper page
  3. [3]Bo L Geurts JJ van der Valk P Polman C Barkhof F Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis Arch Neurol 2007 64 76 80 10.1001/archneur.64.1.76 17210812 · DOI
  4. [4]Bo L Vedeler CA Nyland H Trapp BD Mork SJ Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration Mult Scler 2003 9 323 331 10.1191/1352458503ms917oa 12926836 · DOI · Paper page
  5. [5]Bo L Vedeler CA Nyland HI Trapp BD Mork SJ Subpial demyelination in the cerebral cortex of multiple sclerosis patients J Neuropathol Exp Neurol 2003 62 723 732 12901699
  6. [6]Brownell B Hughes JT The distribution of plaques in the cerebrum in multiple sclerosis J Neurol Neurosurg Psychiatry 1962 25 315 320 10.1136/jnnp.25.4.315 14016083 PMC495470 · DOI
  7. [7]Calabrese M Agosta F Rinaldi F Cortical lesions and atrophy associated with cognitive impairment in relapsing–remitting multiple sclerosis Arch Neurol 2009 66 1144 1150 10.1001/archneurol.2009.174 19752305 · DOI
  8. [9]Calabrese M Grossi P Favaretto A Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study J Neurol Neurosurg Psychiatry 2012 83 49 54 10.1136/jnnp-2011-300414 21890577 · DOI
  9. [10]Carroll WM Jennings AR Ironside LJ Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination Brain 1998 121 293 302 10.1093/brain/121.2.293 9549507 · DOI
  10. [11]Chang A Nishiyama A Peterson J Prineas J Trapp BD NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions J Neurosci 2000 20 6404 6412 10964946 PMC6772992
  11. [15]Franklin RJ Ffrench-Constant C Remyelination in the CNS: from biology to therapy Nat Rev Neurosci 2008 9 839 855 10.1038/nrn2480 18931697 · DOI · Paper page
  12. [16]Gardner C Magliozzi R Durrenberger PF Howell OW Rundle J Reynolds R Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats Brain 2013 136 3596 3608 10.1093/brain/awt279 24176976 · DOI
  13. [17]Geurts JJ Bo L Pouwels PJ Castelijns JA Polman CH Barkhof F Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology AJNR Am J Neuroradiol 2005 26 572 577 15760868 PMC7976495
  14. [18]Geurts JJ Calabrese M Fisher E Rudick RA Measurement and clinical effect of grey matter pathology in multiple sclerosis Lancet Neurol 2012 11 1082 1092 10.1016/S1474-4422(12)70230-2 23153407 · DOI
  15. [19]Gilmore CP Donaldson I Bo L Owens T Lowe J Evangelou N Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord J Neurol Neurosurg Psychiatry 2009 80 182 187 10.1136/jnnp.2008.148767 18829630 · DOI
  16. [20]Gilson J Blakemore WF Failure of remyelination in areas of demyelination produced in the spinal cord of old rats Neuropathol Appl Neurobiol 1993 19 173 181 10.1111/j.1365-2990.1993.tb00424.x 8316337 · DOI
  17. [21]Goldschmidt T Antel J Konig FB Bruck W Kuhlmann T Remyelination capacity of the MS brain decreases with disease chronicity Neurology 2009 72 1914 1921 10.1212/WNL.0b013e3181a8260a 19487649 · DOI · Paper page
  18. [22]Hampton DW Innes N Merkler D Zhao C Franklin RJ Chandran S Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency Am J Pathol 2012 180 1897 1905 10.1016/j.ajpath.2012.01.018 22426338 · DOI
  19. [23]Hinks GL Franklin RJ Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats Mol Cell Neurosci 2000 16 542 556 10.1006/mcne.2000.0897 11083917 · DOI
  20. [24]Howell OW Reeves CA Nicholas R Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis Brain 2011 134 2755 2771 10.1093/brain/awr182 21840891 · DOI · Paper page
  21. [25]Johnson ES Ludwin SK The demonstration of recurrent demyelination and remyelination of axons in the central nervous system Acta Neuropathol 1981 53 93 98 10.1007/BF00689988 7211208 · DOI
  22. [26]Kangarlu A Bourekas EC Ray-Chaudhury A Rammohan KW Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla AJNR Am J Neuroradiol 2007 28 262 266 17296991 PMC7977406
  23. [27]Kidd D Barkhof F McConnell R Algra PR Allen IV Revesz T Cortical lesions in multiple sclerosis Brain 1999 122 17 26 10.1093/brain/122.1.17 10050891 · DOI · Paper page
  24. [28]Kreutzfeldt M Bergthaler A Fernandez M Neuroprotective intervention by interferon-gamma blockade prevents CD8+ T cell-mediated dendrite and synapse loss J Exp Med 2013 10 2087 2103 10.1084/jem.20122143 PMC3782053 23999498 · DOI
  25. [29]Kuhlmann T Miron V Cui Q Wegner C Antel J Bruck W Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Brain 2008 131 1749 1758 10.1093/brain/awn096 18515322 · DOI · Paper page
  26. [30]Kutzelnigg A Lucchinetti CF Stadelmann C Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 2005 128 2705 2712 10.1093/brain/awh641 16230320 · DOI · Paper page
  27. [31]Lassmann H New concepts on progressive multiple sclerosis Curr Neurol Neurosci Rep 2007 7 239 244 10.1007/s11910-007-0036-0 17488590 · DOI
  28. [32]Linington C Engelhardt B Kapocs G Lassman H Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody J Neuroimmunol 1992 40 219 224 10.1016/0165-5728(92)90136-9 1385471 · DOI
  29. [33]Lucchinetti C Bruck W Parisi J Scheithauer B Rodriguez M Lassmann H A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases Brain 1999 122 2279 2295 10.1093/brain/122.12.2279 10581222 · DOI · Paper page
  30. [35]Magliozzi R Howell O Vora A Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 2007 130 1089 1104 10.1093/brain/awm038 17438020 · DOI
  31. [36]Magliozzi R Howell OW Reeves C A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis Ann Neurol 2010 68 477 493 10.1002/ana.22230 20976767 · DOI · Paper page
  32. [37]Manrique-Hoyos N Jurgens T Gronborg M Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis Ann Neurol 2012 71 227 244 10.1002/ana.22681 22367995 · DOI · Paper page
  33. [38]Merkler D Ernsting T Kerschensteiner M Bruck W Stadelmann C A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination Brain 2006 129 1972 1983 10.1093/brain/awl135 16714315 · DOI · Paper page
  34. [40]Penderis J Shields SA Franklin RJ Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system Brain 2003 126 1382 1391 10.1093/brain/awg126 12764059 · DOI
  35. [42]Prineas JW Kwon EE Goldenberg PZ Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions Lab Invest 1989 61 489 503 2811298
  36. [43]Radzun HJ Hansmann ML Heidebrecht HJ Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P Lab Invest 1991 65 306 315 1890811
  37. [44]Roosendaal SD Moraal B Pouwels PJ Accumulation of cortical lesions in MS: relation with cognitive impairment Mult Scler 2009 15 708 714 10.1177/1352458509102907 19435749 · DOI
  38. [45]Shen S Sandoval J Swiss VA Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency Nat Neurosci 2008 11 1024 1034 10.1038/nn.2172 19160500 PMC2656679 · DOI
  39. [46]Shields S Gilson J Blakemore W Franklin R Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination Glia 2000 29 102 10.1002/(SICI)1098-1136(20000101)29:1<102::AID-GLIA12>3.0.CO;2-1 10594929 · DOI
  40. [47]Sim FJ Zhao C Penderis J Franklin RJ The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation J Neurosci 2002 22 2451 2459 11923409 PMC6758320
  41. [48]Stadelmann C Albert M Wegner C Bruck W Cortical pathology in multiple sclerosis Curr Opin Neurol 2008 21 229 234 10.1097/01.wco.0000318863.65635.9a 18451703 · DOI
  42. [49]Stankoff B Aigrot MS Noel F Wattilliaux A Zalc B Lubetzki C Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules J Neurosci 2002 22 9221 9227 12417647 PMC6758026
  43. [50]Wegner C Esiri MM Chance SA Palace J Matthews PM Neocortical neuronal, synaptic, and glial loss in multiple sclerosis Neurology 2006 67 960 967 10.1212/01.wnl.0000237551.26858.39 17000961 · DOI
  44. [51]Woodruff RH Fruttiger M Richardson WD Franklin RJ Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination Mol Cell Neurosci 2004 25 252 262 10.1016/j.mcn.2003.10.014 15019942 · DOI · Paper page
  45. [53]Zhu X Bergles DE Nishiyama A NG2 cells generate both oligodendrocytes and gray matter astrocytes Development 2008 135 145 157 10.1242/dev.004895 18045844 · DOI
  46. [54]Zhu X Zuo H Maher BJ Olig2-dependent developmental fate switch of NG2 cells Development 2012 139 2299 2307 10.1242/dev.078873 22627280 PMC3367441 · DOI

Cited by

Sorted by citations

Authors
Rodriguez, E. G., Wegner, C., Kreutzfeldt, M., Neid, K., Thal, D. R., Jürgens, T., Brück, W., Stadelmann, C., & Merkler, D.
Affiliations
  • Universitätsmedizin Göttingen (DE)
  • University of Geneva (CH)
  • Universität Ulm (DE)
Corresponding author
  • Stadelmann, Christine
  • Merkler, Doron
Venue
Acta Neuropathologica
Published
2014-02-25
Volume
128
Issue
2
Pages
231-246
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2062391876
Cited by
44
References
8
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 1 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 2
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion)
  • reroDoc Digital Library (submittedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
  • GRO (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • National Science Foundation
  • Multiple Sclerosis Society
  • Deutsche Forschungsgemeinschaft
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (128372)
  • Gemeinnützige Hertie-Stiftung
  • Novartis Pharma
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
multiple sclerosis, oligodendrocyte loss, remyelination, oligodendrocyte precursor cells, Nogo-A, Olig2, disease progression, experimental autoimmune encephalomyelitis, cortical lesions, remyelination failure
MeSH terms
Nogo Proteins, Oligodendrocyte Transcription Factor 2, Adult, Aged, Animals, Cell Count, Cerebral Cortex, Chronic Disease, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Proteins, Nerve Tissue Proteins, Oligodendroglia, Rats, Inbred Lew, Disease Progression, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review